Cargando…
A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
Worldwide schistosomiasis continues to be a serious public health problem. Over the past five decades, China has made remarkable progress in reducing Schistosoma japonicum infections in humans to a relatively low level. Endemic regions are currently circumscribed in certain core areas where re-infec...
Autores principales: | Zhou, Yi-biao, Zheng, Hui-min, Jiang, Qing-wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195757/ https://www.ncbi.nlm.nih.gov/pubmed/21981948 http://dx.doi.org/10.1186/1756-3305-4-194 |
Ejemplares similares
-
Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China
por: Zhou, Yi-Biao, et al.
Publicado: (2012) -
Diagnostic Efficacy of Plasma-Based Real-Time PCR for Schistosomiasis Japonica in Mice before and after Treatment with Praziquantel
por: Chen, Cheng, et al.
Publicado: (2023) -
Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis
por: Fukuchi, Takahiko, et al.
Publicado: (2019) -
Human Schistosomiasis Resistance to Praziquantel in China: Should We Be Worried?
por: Seto, Edmund Y. W., et al.
Publicado: (2011) -
Authors' Response to “Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis”
por: Koizumi, Yohei, et al.
Publicado: (2019)